Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AK157D1 in the Treatment of Advanced Solid Tumors Conditions

NCT07847281 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT07847281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AK157D1 in the Treatment of Advanced Solid Tumors Conditions
Lead sponsor
Akeso
Phase
Phase 1
Overall status
Recruiting
Start date
September 30, 2026
Completion date
September 15, 2029
Enrollment
243 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors